MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
4. Triple Helix _ Capture Strategies
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Bioscience Regional Clusters & HotSpots
*Industry: Massachusetts
OS Therapies Inc. (NYSE: OSTX)*
Organization & Developments: OS Therapies
Parents
OS Therapies Inc. (NYSE: OSTX)*
Children
*Clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat and cure Osteosarcoma (OS) and other deadly cancers in kids and adults including ovarian, esophageal, endometrial and lung cancers
*Company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors.
2024: Everything you need to know about OS Therapies’ upcoming IPO
2024: OS Therapies Accepted Into Johnson & Johnson Innovation - JLABS
2024: OS Therapies Announces Positive Efficacy and Safety Data for Ovarian Cancer Therapeutic Candidate Developed Based on Tunable Antibody Drug Conjugate (tADC) Platform Using Proprietary Silicone Linker Platform in Preclinical Models
2024: OS Therapies Completes Phase 2b Trial Dosing, Awaits Key December Data
2025: FDA Fast-Tracks Novel Cancer Drug With $160M Potential Priority Review Voucher
2025: OS Therapies: A Cheap Mid-Stage Biotech Carrying Listeria-Based Immunotherapy
2025: OS Therapies' OST-HER2 Shows 2-Year Survival Benefit in Rare Osteosarcoma
2025: OST-HER2 Shows Significant EFS Improvement in Metastatic Lung Osteosarcoma
Jumps
Finance & Acquisition: OS Therapies
Key People: OS Therapies